MARROSU, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 360.638
NA - Nord America 19.829
AS - Asia 8.171
SA - Sud America 1.143
AF - Africa 162
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 24
Totale 390.001
Nazione #
IT - Italia 354.960
US - Stati Uniti d'America 19.533
SG - Singapore 3.112
CN - Cina 3.043
UA - Ucraina 1.417
SE - Svezia 1.160
BR - Brasile 911
DE - Germania 766
FI - Finlandia 731
VN - Vietnam 661
GB - Regno Unito 540
FR - Francia 479
HK - Hong Kong 279
IN - India 191
CA - Canada 169
KR - Corea 149
NL - Olanda 134
BD - Bangladesh 111
JP - Giappone 91
IQ - Iraq 83
AR - Argentina 82
RU - Federazione Russa 77
MX - Messico 60
PK - Pakistan 59
TR - Turchia 56
PL - Polonia 54
ES - Italia 47
AT - Austria 43
UZ - Uzbekistan 42
CH - Svizzera 41
BE - Belgio 38
IR - Iran 36
ZA - Sudafrica 34
MA - Marocco 33
ID - Indonesia 32
CO - Colombia 30
VE - Venezuela 29
EC - Ecuador 27
IE - Irlanda 27
PH - Filippine 27
AU - Australia 26
AE - Emirati Arabi Uniti 22
EU - Europa 22
SA - Arabia Saudita 22
AZ - Azerbaigian 20
KE - Kenya 20
CL - Cile 19
IL - Israele 19
JM - Giamaica 17
JO - Giordania 17
TN - Tunisia 17
CZ - Repubblica Ceca 16
TH - Thailandia 15
PY - Paraguay 14
MY - Malesia 13
BO - Bolivia 12
CU - Cuba 12
LT - Lituania 12
UY - Uruguay 11
PT - Portogallo 10
TW - Taiwan 10
DO - Repubblica Dominicana 9
RO - Romania 9
SI - Slovenia 9
BG - Bulgaria 8
CR - Costa Rica 8
EG - Egitto 8
LB - Libano 8
MD - Moldavia 8
PE - Perù 8
DZ - Algeria 7
ET - Etiopia 7
NZ - Nuova Zelanda 7
OM - Oman 7
DK - Danimarca 6
GR - Grecia 6
HR - Croazia 6
KZ - Kazakistan 6
LK - Sri Lanka 6
MU - Mauritius 6
PA - Panama 6
AL - Albania 5
EE - Estonia 5
GE - Georgia 5
NG - Nigeria 5
NP - Nepal 5
AO - Angola 4
BY - Bielorussia 4
HN - Honduras 4
HU - Ungheria 4
LU - Lussemburgo 4
MK - Macedonia 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
CY - Cipro 3
GA - Gabon 3
KG - Kirghizistan 3
LV - Lettonia 3
QA - Qatar 3
SV - El Salvador 3
Totale 389.960
Città #
Cagliari 347.657
Uta 5.169
Fairfield 1.686
Ashburn 1.599
Woodbridge 1.597
Singapore 1.475
Chandler 1.412
San Jose 1.103
Houston 983
Boardman 909
Ann Arbor 865
Dallas 813
Wilmington 777
Nyköping 761
Jacksonville 729
Seattle 644
Beijing 576
Dearborn 567
Cambridge 546
Helsinki 479
Los Angeles 344
Nanjing 287
New York 257
Lauterbourg 234
Hong Kong 229
Santa Clara 227
Munich 223
Shanghai 220
The Dalles 216
Boston 206
Rome 196
Hefei 195
Milan 195
Ho Chi Minh City 189
Council Bluffs 139
Hanoi 138
Seoul 137
Buffalo 134
San Diego 111
Shenyang 103
Guangzhou 91
Nanchang 87
São Paulo 84
Orem 80
Redwood City 78
Toronto 77
Dong Ket 72
Hebei 72
London 71
Jiaxing 68
Tianjin 64
Verona 62
Changsha 59
Norwalk 58
Atlanta 56
Chicago 52
Frankfurt am Main 50
Sassari 50
Tokyo 48
Redondo Beach 44
Mountain View 42
Jinan 41
Phoenix 41
Chennai 39
Warsaw 39
Brooklyn 38
Tashkent 37
Brussels 36
Da Nang 36
Montreal 35
San Francisco 35
Orange 34
Stockholm 34
Amsterdam 32
Washington 32
Naples 31
Rio de Janeiro 31
Wuhan 30
Zhengzhou 30
Baghdad 29
Kunming 29
Ningbo 28
Pune 28
Haiphong 27
Leawood 25
Nuremberg 25
Denver 24
Florence 23
Manchester 23
Auburn Hills 22
Dublin 22
Hangzhou 22
Porto Alegre 22
Augusta 21
San Mateo 21
Falls Church 20
Mumbai 20
Paris 19
Baku 18
Bologna 18
Totale 376.809
Nome #
Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1(B9) Drosophila melanogaster Genetic Model of Parkinson's Disease 5.429
Drosophila model for parkinson’s disease: function, anatomy and screening with phytoterapics from Sardinian and Indian flora (Withania somnifera and Mucuna pruriens) 5.078
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: drug effects of Withania somnifera (Dunal) administration 5.022
VGF protein and its C-terminal derived peptides in amyotrophic lateral sclerosis: Human and animal model studies 4.784
Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS 4.319
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.287
PROP bitter taste-induced brain activation-deactivation in gustatory signal processing: a functional magnetic resonance imaging (fMRI) study 4.199
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.083
OLFACTORY DYSFUNCTION AS POTENTIAL BIOMARKER IN NEURODEGENERATIVE DISORDERS 4.043
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 3.865
Morningness Eveningness Questionnaire (MEQ) and salivary DLMO determination: a reliable method of evaluation for circadian pattern 3.731
The neurosteroidogenic enzyme 5α-reductase mediates psychotic-like complications of sleep deprivation 3.707
Impaired sense of smell in a Drosophila Parkinson's model. 3.662
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 3.543
Brain activation pattern during perception of PROP bitter taste using functional magnetic resonance imaging (fMRI) 3.529
Drosophila Parkinson's mutant display olfactory impairment both to natural and synthetic compounds 3.512
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.478
The re-organization of functional brain networks in pharmaco-resistant epileptic patients who respond to VNS 3.427
F-Wave duration as a specific and sensitive tool for the diagnosis of restless legs syndrome/Willis-Ekbom disease 3.427
VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy 3.402
A multimodal neuroimaging approach in patients with early diagnosis of Parkinson's disease: Correlations between f-MRI with fine motor tasks, EEG and clinical tests 3.268
Parkinsonism and dementia are negative prognostic factors for the outcome of subdural hematoma 3.259
EEG functional network topology is associated with disability in patients with amyotrophic lateral sclerosis 3.243
Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke 3.181
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.122
Focal 123I-FP-CIT SPECT abnormality in a patient with midbrain vascular Parkinsonism 3.100
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings 2.955
TLQP peptides in amyotrophic lateral sclerosis: possible blood biomarkers with a neuroprotective role 2.944
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 2.941
Involvement of GABA in mirror focus: A case report 2.939
Influence of parkinsonism on Hitler's decision-making 2.915
Functional brain connectivity analysis in amyotrophic lateral sclerosis: an EEG source-space study 2.910
The effect of epoch length on estimated EEG functional connectivity and brain network organisation 2.826
VGF peptides as novel biomarkers in Parkinson’s disease 2.775
Polimorfismo Val66Met e valori di BDNF in pazienti affetti da epilessia farmacoresistente trattati con stimolazione del nervo vago (VNS). 2.772
Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients 2.716
Imaging and Genomic Classification of Brain Alteration Induced By Gustatory Bitter Stimulus, A Pilot Study 2.715
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.677
Networks in the brain: from neurovascular coupling of the BOLD effect to brain functional architecture 2.670
Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation 2.609
New vistas on VNS mechanism of action 2.606
Overlap Parasomnia Disorder in a case of Creutzfeldt-Jakob Disease 2.599
Reduction of fat mass by vagus nerve stimulation in rats 2.559
Vagus Nerve Stimulation Reduces Body Weight and Fat Mass in Rats 2.549
Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels 2.539
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.503
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.445
Clinical and genetic characteristics of late-onset Huntington's disease 2.415
Graph theory-based analysis of EEG during nREM sleep reveals changes in functional connectivity in sleep-related hypermotor epilepsy (SHE) 2.409
null 2.394
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.360
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.360
Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease 2.344
Blockade of 5-alpha reductase reduces compulsive behaviors in mice 2.316
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.309
Clinical manifestations of intermediate allele carriers in Huntington disease 2.285
Specificity and sensitivity of F-waves parameters in diagnosis of RLS/WED 2.233
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.213
Sleep motor activity in amyotrophic lateral sclerosis 2.201
Effects of vagus nerve stimulation on BDNF gene expression and hippocampal plasticity in the rat 2.176
Occurence and DAergic therapy correlates of REM sleep behavior disorder in patients with Parkinson Disease 2.166
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.163
Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice 2.153
Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus 2.145
Neuroimaging, Networking and Systems Biology: The New Way to Investigate Pathologies with Neurological System Implications. The example of Tourette Syndrome as a Pilot Study 2.143
Suicide and Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease 2.126
Increase in 20-50 Hz (gamma frequencies) power spectrum and synchronization after chronic vagal nerve stimulation 2.101
How individual habits fit/unfit social norms: from the historical perspective to a neurobiological repositioning of an unresolved problem 2.078
Relationship of morningness-eveningness questionnaire score to Melatonin DLMO measured from saliva sample: circadian patterns of a normal subjects group and a delayed phase syndrome 2.077
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.065
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 2.019
Assessment of heart rate variability in a population of Sardinian patients affected by amyotrophic lateral sclerosis 2.013
A multivariate approach for the brain impairment in patients with liver cirrhosi 2.000
Chronic effects of vagus nerve stimulation on body fat mass in the rat 1.976
Reduction in rat body weight and fat mass without affecting food intake induced by vagus nerve stimulation 1.953
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 1.929
null 1.926
ECG-based cardiopulmonary coupling for sleep stability assessment in patients with amyotrophic lateral sclerosis 1.919
Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis 1.909
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.894
Loss of heart rate variability in ALS: Time and frequency domain assessment. 1.893
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.889
Discordance between Dopamine transporter deficit and motor symptoms in a case of REM sleep behavior disorder 1.888
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.876
The implication of neuroactive steroids in tourette's syndrome pathogenesis: A role for 5α-reductase? 1.864
Dissociation Between Neurovegetative Signs and Subjective Symptoms in a Case of Idiopathic Pilomotor Seizures 1.848
EEG spectral coherence analysis in nocturnal epilepsy 1.815
Role of DA-ergic therapy on REM sleep behaviour disorder in a large population of Parkinsonians 1.796
Spectral coherence analysis in EEG nocturnal epilepsy recordings 1.773
Lack of antidepressant like behavioral effects of chronic vagus nerve stimulation in the rat despite neurochemical end molecular antidepressant like effects 1.762
Respiratory sleep disorders in Jeune syndrome: a case description 1.757
Facial synkinesis as a first symptom of multiple sclerosis 1.752
Long-latency potential study in minimal hepatic hencephalopaty 1.751
Motor sleep features in a Sardinian population of amyotrophic lateral sclerosis patients. 1.712
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.691
Leucine-rich repeat kinase 2 (LRRK2) gene mutations in degenerative parkinsonism 1.686
Prevalence of Huntington's disease in Southern Sardinia, Italy 1.650
Long term vagus nerve stimulation (VNS) modifies EEG coherences and frequency power spectrum in partial epilepsy 1.639
Isolation rearing-induced reduction of brain 5 alpha-reductase expression: Relevance to dopaminergic impairments 1.625
Role of MR spectroscopy in patients with temporal lobe epilepsy (TLE) 1.597
Totale 262.898
Categoria #
all - tutte 494.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 494.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.779 0 0 0 0 0 0 0 0 0 0 0 2.779
2021/202217.453 2.242 1.464 1.074 1.207 1.687 1.290 929 845 1.349 1.629 1.749 1.988
2022/202322.973 2.139 3.064 2.767 2.045 1.897 2.202 1.185 1.859 1.392 1.404 1.886 1.133
2023/202423.308 1.418 1.098 1.041 1.628 2.416 3.625 3.391 1.643 1.066 1.732 2.049 2.201
2024/202536.739 6.047 8.461 4.798 4.104 4.331 2.595 3.373 391 811 571 506 751
2025/202615.253 908 623 1.648 1.348 1.312 1.464 2.208 1.038 1.369 1.699 917 719
Totale 390.620